• AAPL 169.02
  • TSLA 162.13
  • AMZN 176.59
  • MSFT 409.06
  • INTC 34.5
  • EURUSD 1.0709
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. MCAG.NASDAQ

Mountain Crest Acquisition Corp V (MCAG NASDAQ) stock market data APIs

$10.75 0(0%) as of April 24, 2024

Mountain Crest Acquisition Corp V Financial Data Overview

10.75
10.75
-
10.75
10.75
10.22-11.4
33 890 K
3 170 K
0
-0.702
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MCAG',
Type: 'Common Stock',
Name: 'Mountain Crest Acquisition Corp V',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: '1859035',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-12-03',
InternationalDomestic: NULL,
Sector: 'Financial Services',
Industry: 'Shell Companies',
HomeCategory: NULL,
IsDelisted: false,
}

Mountain Crest Acquisition Corp V Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -0.36
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Mountain Crest Acquisition Corp V Earnings via APIs

  • Latest Release 2023-09-30
  • EPS/Forecast NaN

Get Mountain Crest Acquisition Corp V End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Mountain Crest Acquisition Corp V latest news via APIs

Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market

NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasda...
  • MANAGEMENT STATEMENTS
  • MOUNTAIN CREST ACQUISITION CORP. V
  • NASDAQ:MCAG

AUM Biosciences Doses First Patient in Phase 2 Clinical Trial of AUM001 in Metastatic Colorectal Cancer

SINGAPORE and BETHESDA, Md., May 30, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company focused on discovering and developing precision onc...
  • AUM BIOSCIENCES PTE LTD
  • CLINICAL STUDY
  • HEALTH
  • PRODUCT / SERVICES ANNOUNCEMENT
Do you have any questions?
support@eodhistoricaldata.com